United Kingdom

**Abstract authors:**

Ria Pal¹, Katherine Xiong¹, Sarah Lee¹

¹Stanford University

**Abstract body:**

Introduction Rapid stroke diagnosis via emergent neuroimaging can prevent secondary injury. Pediatric stroke alerts, however, are infrequent, leading to limited opportunities to practice protocols. Pediatric stroke alerts also require urgent collaboration between multiple discrete teams to coordinate imaging, sedation, hyperacute treatments, and other aspects of care. This can result in communication breaks, logistical challenges, and unclear divisions of responsibility. Objective By identifying stakeholder needs across disciplines, we sought to streamline our ED stroke alert process and improve time-to-imaging for children presenting acutely with suspected stroke. Methods We performed a retrospective assessment of stroke alerts in the Stanford pediatric ED from 2016-2021. Root cause analysis was performed using the 5 Whys methodology and fishbone diagram. Surveys were conducted with neurology, emergency medicine, pediatric anesthesia, neuro-IR, and neuroradiology stakeholders regarding potential sources of imaging delays. Staged interventions were implemented between January-June 2022 using Plan-Do-Study-Act cycles. Time-to-imaging was measured for each stroke alert pre- and post-intervention. Results Surveys indicated that key drivers of imaging delays could be categorized as provider protocol familiarity, information and equipment availability, and process and outcome transparency. Interventions were designed to address each key driver (Figure 1). Post-implementation, short-term analysis demonstrated a consistent but as yet-statistically insignificant decrease in mean time-to-imaging for CT (47±31 to 22±13 minutes, p=0.26), MRI without sedation (67±52 to 49±22 minutes, p=0.15), and MRI with sedation (151±42 to 92±7 minutes, p=0.07, Figure 2 ). Conclusions Communication across teams is essential for effective pediatric stroke care. We offer our process improvement experience with adaptable interventions at a large, tertiary-care hospital system.

IPSO 2023

Fostering Collaboration in Acute Pediatric Stroke Care: Lessons from Creating an Interdisciplinary Alert System

**[Download Full Agenda](https://drive.google.com/file/d/1Dm9lJyTfJrvd7-StaHFmUmhXC-J_UgTj/view?usp=sharing)**

Dear IPSO Virtual Conference Attendees:

Welcome to IPSO’s first-ever conference! We are delighted to bring together experts from multiple disciplines and six continents to provide a diverse perspective on pediatric cerebrovascular disease. 

A few quick words about what to expect. Two important goals of this conference are to (1) foster a sense of community and (2) identify global priorities for our field. Hence, the program includes short presentations on an array of clinical controversies and dedicates more time to panel discussions with a live chat function so that everyone can participate. We are excited to announce IPSO is able to offer 8.75 CME units for the virtual conference. If you would like to claim CME credits, please email <membership@internationalpediatricstroke.org>. 

We want to hear from you! Planning for the [IPSO Founding Members’ Congress](https://internationalpediatricstroke.org/2022-congress/) in Vienna, April 24-26, 2022, will commence as soon as the Virtual Conference ends. Let us know your priorities through the live chat function, via email, or by submitting a symposium idea. Based on your input, the Scientific Program Committee will select the topics that we will address in greater depth when we meet again in the spring.

We hope you find the Virtual Conference both interesting and educational, and hope to see you in person in Vienna, or at another IPSO meeting in the future. 

Warm regards,

Heather Fullerton, IPSO President

Adam Kirton, IPSO Vice-President

Lori Jordan, IPSO Secretary & Treasurer


![](https://assets.underline.io/uploads/markdown_image/1/image/1c71a0aebc49947c923a7920d9f28857.jpg)



 
 
 


 



*Header Photo Credit: Helen Carlson, Ph.D, Alberta Children's Hospital*

To access IPSO 2021, you must pre-register for the conference.  Instructions on how to access the event will be provided directly to attendees and included on the IPSO 2021 conference website. [Register now](https://internationalpediatricstroke.org/2021-congress/registration/).

IPSO 2021

Welcome to the first IPSO Virtual Conference. The mission of the virtual conference is to unify the global community of professionals engaged in research and clinical care for children with cerebrovascular diseases, and chart a path forward for multinational, multidisciplinary efforts. Please go here to access the virtual conference platform- <a href="https://underline.io/events/157/reception">Reception page</a>.

poster

Dear IPSO Virtual Conference Attendees:

Welcome to the IPSO 2023 Virtual Conference. We are delighted to bring together experts from multiple disciplines and six continents to provide a diverse perspective on pediatric cerebrovascular disease.

A few quick words about what to expect. Two important goals of this conference are to (1) foster a sense of community and (2) identify global priorities for our field. We encourage you to express your thoughts live in through the chat function to provide a global perspective on all topics. Please introduce yourself in the chat, so everyone knows where you are attending from.

We are excited to announce IPSO is able to offer 9.5 CME units for the virtual conference. If you would like to claim CME credits, please email membership@internationalpediatricstroke.org. 

We want to hear from you! Planning for IPSO 2024 Congress on March 22nd-24th in Toronto, Canada, will commence as soon as the Virtual Conference ends. Let us know your priorities through the live chat function, via email, or by submitting a symposium idea. Based on your input, the Scientific Program Committee will select the topics that we will address in greater depth when we meet again in the spring.

We hope you find the Virtual Conference both interesting and educational, and hope to see you in person in Toronto, or at another IPSO meeting in the future.

Warm regards,

Heather Fullerton, IPSO President 
Maja Steinlin, IPSO Vice-President 
Lori Jordan, IPSO Secretary & Treasurer 
Noma Dlamini, IPSO Scientific Program Committee Chair 


The International Pediatric Stroke Organization (IPSO) 2023 Virtual Conference is April 28-29th, 2023. The mission of the virtual conference is to unify the global community of professionals engaged in research and clinical care for children with cerebrovascular diseases, and chart a path forward for multinational, multidisciplinary efforts. Similar to the IPSO 2021 Virtual Conference, IPSO has partnered with Underline to host this virtual conference. 

The 2023 IPSO Virtual Conference will offer:

* A highly interactive format: brief recorded talks followed by live panel discussions with audience participation through a chat function and live audience surveys
* Optional break-out groups for IPSO committees, working groups, councils
* Poster sessions available on-demand throughout the conference with a chat function for the audience to comment for ask questions of the presenters

Disclaimer: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of UCSF and the International Pediatric Stroke Organization (IPSO) and Hospital for Sick Children, and Vanderbilt University Medical Center. UCSF is accredited by the ACCME to provide continuing medical education for physicians.

 UCSF designates this live activity for a maximum of 9.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact membership@internationalpediatricstroke.org if you would like to claim CME for the IPSO 2023 Virtual Conference. 

**About** 
Founded in February, 2019, we are an organization of health professionals, scientists and patient advocates who care about stroke and other cerebrovascular diseases in childhood. We developed out of our original collaborative network, the International Pediatric Stroke Study (IPSS), and now aim to broaden the scope of our mission beyond research.

* Our mission is to improve the lives of children worldwide with cerebrovascular disease through research, education, clinical care and advocacy.

* Our Vision is a world in which international, multidisciplinary collaborations advance the understanding, care, and outcomes of childhood cerebrovascular disease.

To access IPSO 2023 site, please register [here](https://internationalpediatricstroke.org/2023-virtual-conference/registration/). 

The mission of the International Pediatric Stroke Organization (IPSO) 2023 Virtual Conference is to unify the global community of professionals engaged in research and clinical care for children with cerebrovascular diseases, and chart a path forward for multinational, multidisciplinary efforts. 



**Abstract authors:**

Akshat Pai¹, Samyami Chowdhury¹, Daniel Nichol¹, Heather Fullerton², Sahar Hassanein³, Lauren Beslow⁴, Christine Fox², Nomazulu Dlamini¹, On Behalf of IPSS Investigators

¹Hospital for Sick Children, ²UCSF Benioff Children's Hospital, ³Ain Shams University, ⁴Children's Hospital of Philadelphia

**Abstract body:**

Introduction Although pediatric hemorrhagic stroke (HS) accounts for 50% of childhood strokes, large pediatric stroke registries like the International Pediatric Stroke Study (IPSS) have focused on ischemic stroke. Previously, the IPSS has not collected data on social determinants of health (SDOH). Objective We sought to expand the IPSS registry to include HS and begin novel data collection on SDOH. Methods We developed new IPSS data collection forms related to HS and SDOH. After IRB approval, IPSS sites enrolled children (aged >28 days - 18 years) who had HS between 2004 and 2023. Local sites conducted a retrospective chart review. SDOH were collected by guardian report. We centrally analyzed data including frequencies and proportions of age, sex, race, ethnicity, language, educational attainment, and household income. Preliminary Results To date, ten IPSS sites enrolled 120 children (58% male) with HS. The median age at onset of stroke was 9.9 years (IQR 4.3-14.0). Vascular malformations were identified in 53 patients (44%). Arteriovenous malformation (n = 33) was the most commonly reported etiology, followed by aneurysm (n = 6) and cavernous malformation (n = 2). Race and ethnicity data were available in 115 (95%) patients (Table 1). SDOH were reported for 50 (42%) families. Among these, 15 (30%) reported speaking a different language than their healthcare provider and 8 (53%) required an interpreter. Of 36 families for whom primary caregiver educational attainment data and household income data was available, 19 (53%) obtained a Bachelors degree or higher, whereas 28 (78%) reported their household income. Significance This is a preliminary analysis of a novel international HS registry. Our interim analysis suggests that a significant proportion of families of children with HS may have language barriers. In this ongoing registry study, we plan to further examine SDOH in children with hemorrhagic stroke.

Social Determinants of Health and Pediatric Hemorrhagic Stroke: A New Facet of the IPSS

**Abstract authors:**

Alex Devarajan¹, Mais Al-Kawaz¹, Jessica Bonet¹, Daryl Goldman¹, Christina Rossitto¹, Michelle Sorscher¹, Peter Morgenstern¹, Tomoyoshi Shigematsu¹, Alejandro Berenstein¹, Johanna Fifi¹

¹Icahn School of Medicine at Mount Sinai

**Abstract body:**

Introduction Patients with Vein of Galen malformations (VOGM) can develop significant angiogenesis leading to hemodynamic and structural remodeling. This results in an extensive fine angiogenic network fistulizing to the vein of Galen. In patients with angiogenic networks, transarterial embolization (TAE) is challenging due to poor penetration and access while transvenous approaches (TVE) carry a risk of hemorrhage from pathologic vasculature. These patients present early and symptomatically and can have devastating outcomes if not treated. Objective We illustrate the case of a pediatric patient who presented with an angiogenic VOGM ultimately treated by staged TAE with a miniature dual-lumen balloon microcatheter (DLBC) and curative TVE. Case Presentation A 12-month-old boy presented after VOGM was identified during workup for progressive hydrocephalus. Endovascular embolization was offered. The infant underwent five staged TAE, followed by curative TVE via pressure cooker technique. Initial pre-embolization angiogram demonstrated a diffuse vascular network within the third ventricle and choroidal fissure superiorly feeding the malformation. Because the network complicated fistulous point access, a miniature DLBC was utilized to achieve distal pedicle flow arrest and partial network devascularization. Postoperatively, the embolization was complicated by IVH and hydrocephalus requiring an ETV with no lasting neurological deficit. For the final embolization, given the arterial morphology and progressive venous reduction, TVE was the technically easiest choice to achieve angiographic cure. Follow-up angiogram demonstrated complete obliteration of the malformation and subsequent clinical follow-up demonstrated improvements in milestones. Conclusion Through a combination of new technologies and techniques, technically challenging VOGMs are now curable. The patient is able to achieve a relatively normal quality of life due to timely and effective treatment.

Angiographic Cure of a Highly Angiogenic Vein of Galen Malformation by Staged Transarterial and Transvenous Embolization: Case Report

**Abstract authors:**

Alex Devarajan¹, Jessica Bonet¹, Alexander Schupper¹, Christina Rossitto¹, Michelle Sorscher¹, Alejandro Berenstein¹, Johanna Fifi¹, Tomoyoshi Shigematsu¹

¹Icahn School of Medicine at Mount Sinai

**Abstract body:**

Introduction Vein of Galen Malformations (VOGM) are congenital arteriovenous malformations (AVM) primarily treated by endovascular embolization via transarterial (TAE) or transvenous (TVE) approaches. TVE can be utilized to close the malformation but carries risk of venous congestion and redirection of venous outflow with significant neurologic consequences. Objective Here, we illustrate the atypical use of an intracranial venous sinus stent to improve normal venous outflow after TVE in the case of a pediatric patient with VOGM. Case A 3-year-old girl presented for continued management of VOGM. She had received six prior TAEs at the senior author's institution: after progressive reduction of the malformation, she was a suitable candidate for TVE. Pre-embolization angiogram demonstrated a choroidal type VOGM with venous hypertension: the vein of Galen drained retrograde through the vein of Labbe, the left transverse sinus drained into cortical cerebellar veins without opacification of the left sigmoid sinus, and stenosis of the right sigmoid-jugular junction was present. Balloon angioplasty of the right sigmoid-jugular junction was performed to aid guide catheter navigation. After TVE by pressure cooker technique, balloon-assisted venous sinus stenting was performed at the right sigmoid-jugular junction to aid normal venous sinus drainage. Post-embolization angiogram demonstrated reduced shunting through the malformation and reduced aberrant cortical venous drainage. Shunted blood mainly drained to the right transverse-sigmoid sinuses with marked improvement of venous diameter and flow. The patient experienced no postoperative complications and clinical follow-up demonstrated improvement in milestones. A second TVE resulted in complete occlusion. Conclusion In patients with VOGM and venous hypertension receiving TVE, venous sinus stenting may be a safe and effective option to reduce aberrant cortical venous drainage and improve normal outflow.

Adjunctive Venous Sinus Stenting in Transvenous Embolization of Vein of Galen Malformation: Case Report

**Abstract authors:**

Zokirzhon Zokhidov¹, Matvey Livshits¹, Inna Shchederkina¹, Gennady Chmutin¹, Sergey Ozerov¹, Alexander Levov¹, Madina Berdieva¹, Anastasia Vergizovа¹

¹Morozov Children's Clinical Hospital

**Abstract body:**

Relevance: Arteriovenous malformation (AVM) in children is a risk factor for hemorrhagic stroke. Materials: The study included 72 children who applied to "Morozov Children's City Clinical Hospital, with a diagnosis of AVM of the cerebral vessels with the presence of intracerebral hematoma. Age ranged from 1 month. up to 18 years old, the median age at diagnosis was 9.6. Boys vs girls-36(50%) vs 35 (50%) Methods: Of 72 children, surgical treatment was performed in 61. Seven patients were not operated on, after stabilization of their condition, they were referred for stereotaxic radiosurgery. 4 patients died. Cerebral deficit was the leading symptom in 52 patients. In 17 patients, the assessment of focal symptoms was difficult due to the severity of the condition. The level of impaired consciousness: clear consciousness in 17 (23.6%), stunning in 23 (31.9%), stupor in 15 (20.9%), coma in 17 (23.6%). The most common localization of AVMs is the parietal lobe. Distribution of patients according to Spetzler-Martin gradation: AVM: type I -- 9 (12.5% %), type II -- 21 (29.2%), type III -- 26 (36.1%), IV -- 13 (18, 1%), V -- 3 (4.1%) patients. The volume of intracranial hematoma ranged from 9 ml to 130 ml. The results: based on the timing of admission to the hospital, the severity of the patient's condition, the size and location of the hematoma, its relationship to the mid-stem and basal structures, a decision was made on the need and extent of surgical intervention. Type of operation: microsurgical in 31 (51%) patients, embolization in 12 (20%) patients and combined intervention (microsurgery + embolization) - in 18 (29%) patients. Outcome: complete regression of neurological symptoms in 34 (55.7%) patients, moderate disability in 20 (32.8%) patients, severe disability in -7 (11.5%) patients. Conclusion: Surgical tactics as early as possible allows to achieve good outcomes in most patients.

Premium content

Next from IPSO 2023

Social Determinants of Health and Pediatric Hemorrhagic Stroke: A New Facet of the IPSS

Similar lecture

Pediatric acute stroke response protocols